Study of Seroprevalence of Anti-SARS-CoV2 Among Children of Hospital Workers in AP-HP
NCT ID: NCT04442087
Last Updated: 2025-11-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
563 participants
INTERVENTIONAL
2020-06-19
2021-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Seroprevalence and Immunoprotection Against COVID-19 in Parisian Children
NCT04490811
Immunity Against SARS-CoV2 in Children and Their Parents / COVID-19
NCT04355533
COVID-19 Infection and Transmission in Exposed, Confined and Community-based Infants
NCT04413968
COVID-19 Seroprevalence in Pregnant Women and Blood Donors
NCT04893057
Establishment of a Biological Collection During COVID-19 Serological Screening in APHP Professionals (COVID-HOP)
NCT04418375
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Serology SARS-CoV2
Collect serum for Serology SARS-CoV2 at inclusion
Data collection
Collect clinical and demographic data, habitus, Lifestyle Counseling at inclusion
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Individuals aged over 18, having a professional activity at the APHP (employees, interns, volunteers)
2. Affiliated to a social security regimen
3. Have at least one child under the age of 18 living in the same house.
4. have signed consent
Child (ren), spouse and other member (s) residing at household:
Exclusion Criteria
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
URC-CIC Paris Descartes Necker Cochin
OTHER
Assistance Publique - Hôpitaux de Paris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Solen KERNEIS, MD
Role: STUDY_DIRECTOR
Assistance Publique - Hôpitaux de Paris
Flore ROZENBERG, MD, PhD
Role: STUDY_DIRECTOR
Assistance Publique - Hôpitaux de Paris
Jean-Marc TRELUYER, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Assistance Publique - Hôpitaux de Paris
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre d'investigation clinique (CIC) Necker Cochin in Necker Children's Hospital
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-A01480-39
Identifier Type: REGISTRY
Identifier Source: secondary_id
APHP200627
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.